https://markets.businessinsider.com/news/stocks/corvus-announces-new-interim-data-from-phase-1-trial-of-soquelitinib-1034795810
Corvus announces new interim data from Phase 1 trial of soquelitinib | Markets Insider
Corvus Pharmaceuticals (CRVS) announced new interim data from the randomized, double-blind, placebo-controlled Phase 1 clinical trial evaluating...